Vaso Occlusive Crisis Market Players:
- Novartis Pharmaceuticals Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bristol-Myers Squibb
- Pfizer Inc.
- Global Blood Therapeutics
- AstraZeneca
- Sanofi
- GlaxoSmithKline
- Regeneron Pharmaceuticals
- Bluebird Bio
- Emmaus Life Sciences, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of vaso occlusive crisis is evaluated at USD 12.4 billion.
The global vaso occlusive crisis market size was worth around USD 11.56 billion in 2025 and is set to register a CAGR of more than 8.1%, exceeding USD 25.19 billion revenue by 2035.
By 2035, the Asia Pacific region is anticipated to command a 38% share of the vaso occlusive crisis market, bolstered by expanding collaborative research and clinical trials.
Key players in the market include Novartis Pharmaceuticals Corporation, Bristol-Myers Squibb, Pfizer Inc., Global Blood Therapeutics, AstraZeneca, Sanofi.
